On May 16, Avanir Pharmaceuticals Inc (NASDAQ:AVNR) VP Christine Ocampo unloaded 37,496 shares of the stock in a transaction dated Friday, May 16th. The stock was sold at an average price of $5.05, for a total transaction of $189,354.80. Following the completion of the transaction, the vice president now directly owns 81,981 shares of the company’s stock, valued at approximately $414,004. Avanir Pharmaceuticals Inc (NASDAQ:AVNR) net profit margin is -86.70% and weekly performance is 11.39%. On last trading day company shares ended up $5.28. Analysts mean target price for the company is $9.29. Avanir Pharmaceuticals Inc (NASDAQ:AVNR) distance from 50-day simple moving average (SMA50) is 28.57%.
Geron Corporation (NASDAQ:GERN) EVP Melissa Kelly Behrs sold 4,826 shares of the stock on the open market in a transaction that occurred on Thursday, May 29th. The stock was sold at an average price of $ 2.10, for a total transaction of $ 10,134.60. Geron Corporation (NASDAQ:GERN) shares fell -1.89% in last trading session and ended the day on $2.08. Gross its return on assets is -38.30%. Geron Corporation (NASDAQ:GERN) quarterly performance is -56.30%.
On 1st, June Boyd Gaming Corporation (NYSE:BYD) EVP Marianne Boyd Johnson sold 20,000 shares of the stock on the open market in a transaction that occurred on Thursday, May 29th. The stock was sold at an average price of $11.02, for a total transaction of $220,400.00. Following the completion of the sale, the executive vice president now directly owns 120,814 shares of the company’s stock, valued at approximately $1,331,370. Boyd Gaming Corporation (NYSE:BYD) shares moved down -0.64% in last trading session and was closed at $10.95, while trading in range of $10.89 – $11.10. Boyd Gaming Corporation (NYSE:BYD) year to date (YTD) performance is -2.75%.
Ironwood Pharmaceuticals Inc (NASDAQ:IRWD) COO Michael J. Higgins sold 50,000 shares of Ironwood Pharmaceuticals stock in a transaction dated Thursday, May 29th. The stock was sold at an average price of $14.56, for a total value of $728,000.00. Following the transaction, the chief operating officer now directly owns 300,000 shares in the company, valued at approximately $4,368,000. Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) ended the last trading day at $14.32. Company weekly volatility is calculated as 3.35% and price to cash ratio as 5.95. Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) showed a positive weekly performance of 1.56%.
On May 31, RetailMeNot Inc (NASDAQ:SALE) CEO G Cotter Cunningham sold 21,000 shares of the stock on the open market in a transaction that occurred on Friday, May 30th. The shares were sold at an average price of $25.68, for a total value of $539,280.00. Following the sale, the chief executive officer now directly owns 385,341 shares of the company’s stock, valued at approximately $9,895,557. RetailMeNot Inc (NASDAQ:SALE) net profit margin is 4.60% and weekly performance is 1.07%. On last trading day company shares ended up $25.50. Analysts mean target price for the company is $44.80. RetailMeNot Inc (NASDAQ:SALE) distance from 50-day simple moving average (SMA50) is -18.44%.
Leave a Reply